Literature DB >> 15581498

Critical role of cathepsin-inhibitors for autoantigen processing and autoimmunity.

Naozumi Ishimaru1, Rieko Arakaki, Nobuhiko Katunuma, Yoshio Hayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15581498     DOI： 10.1016/j.advenzreg.2003.11.004

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN： 0065-2571


× No keyword cloud information.
  4 in total

1.  Enhanced anti-serpin antibody activity inhibits autoimmune inflammation in type 1 diabetes.

Authors:  Jan Czyzyk; Octavian Henegariu; Paula Preston-Hurlburt; Raman Baldzizhar; Christine Fedorchuk; Enric Esplugues; Kim Bottomly; Frans K Gorus; Kevan Herold; Richard A Flavell
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

2.  Anti-serpin antibody-mediated regulation of proteases in autoimmune diabetes.

Authors:  Raman Baldzizhar; Christine Fedorchuk; Mithilesh Jha; Chozhavendan Rathinam; Octavian Henegariu; Jan Czyzyk
Journal:  J Biol Chem       Date:  2012-11-29       Impact factor: 5.157

Review 3.  Structure-based development of specific inhibitors for individual cathepsins and their medical applications.

Authors:  Nobuhiko Katunuma
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

Review 4.  The Role of Proteases and Serpin Protease Inhibitors in β-Cell Biology and Diabetes.

Authors:  Yury Kryvalap; Jan Czyzyk
Journal:  Biomolecules       Date:  2022-01-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.